Home J&J MedTech

Timothy Irving - Account Executive, J&J MedTech - Johnson

Johnson & Johnson MedTech acquires heart implant company Laminar

MedTech

J&J loses challenge to $302 million judgment over pelvic mesh

MedTech

Johnson & Johnson Institute Continuing Education Courses

Tim Schmid

Home J&J MedTech

Home - Investor Day

Home J&J MedTech

J&J highlights Abiomed's first year in 2023 medtech earnings

Home J&J MedTech

J&J MedTech gets Japanese regulatory approval for Varipulse PFA